Aier Eye Hospital is preparing for a listing in Hong Kong, expected to become the first "A+H" ophthalmology hospitalWallstreetcn·Mar 17 at 11:21 AM300015-1.35%
Aier Eye Hospital plans to go public in Hong Kong and is indeed "ready to shoot."Wallstreetcn·Mar 17 at 10:50 AM02219-0.79%300015-1.35%
Aier Eye Hospital is reportedly planning to go public on the Hong Kong Stock Exchange. (Bloomberg)Wallstreetcn·Mar 9 at 06:58 AM06622-1.39%02219-0.79%
The "Implementation Rules for the Supervision and Administration of the Use of Medical Security Fund" have been announced and will take effect on April 1Wallstreetcn·Feb 13 at 01:32 PM300015-1.35%512010-1.08%
Goldman Sachs upgraded ZHIFEI-BIOL from Neutral to Buy, with a target price of 29 RMB. Goldman Sachs upgraded Aier from Neutral to Buy, with a target price of 15 RMBWallstreetcn·Jul 28, 2025 at 09:49 AM300122-1.18%300015-1.35%
Aier: Net profit in the first quarter was 1.05 billion yuan, a year-on-year increase of 16.71%Wallstreetcn·Apr 24, 2025 at 01:03 PM300015-1.35%
